Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.

Article  PubMed  Google Scholar 

Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond). 2019;39:22.

PubMed  PubMed Central  Google Scholar 

Safran HP, Winter K, Ilson DH et al. Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022;23:259–269.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.

Article  PubMed  Google Scholar 

Guan X, Liu C, Zhou T, et al. Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma. Biosci Rep. 2020;40:379.

Article  Google Scholar 

Pech O, May A, Manner H et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652-660 e651.

Article  PubMed  Google Scholar 

Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol. 1984;132:828–832.

Article  CAS  PubMed  Google Scholar 

Chow MT, Luster AD. Chemokines in cancer. Cancer Immunol Res. 2014;2:1125–1131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song X, Greiner-Tollersrud OK, Zhou H. Oral microbiota variation: a risk factor for development and poor prognosis of esophageal cancer. Dig Dis Sci. 2022;67:3543–3556.https://doi.org/10.1007/s10620-021-07245-2.

Article  PubMed  Google Scholar 

Stone MJ, Hayward JA, Huang C et al. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18:342.

Article  PubMed  PubMed Central  Google Scholar 

Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res. 2010;106:91–111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas JK, Mir H, Kapur N, Bae S, Singh S. CC chemokines are differentially expressed in breast cancer and are associated with disparity in overall survival. Sci Rep. 2019;9:4014.

Article  PubMed  PubMed Central  Google Scholar 

Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev. 2002;13:143–154.

Article  CAS  PubMed  Google Scholar 

Liubomirski Y, Lerrer S, Meshel T et al. Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer. Front Immunol. 2019;10:757.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia SN, Han YB, Yang R, Yang ZC. Chemokines in colon cancer progression. Semin Cancer Biol. 2022;86(Pt 3):400–407.

Article  CAS  PubMed  Google Scholar 

Bose S, Saha P, Chatterjee B, Srivastava AK. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy. Semin Cancer Biol. 2022;86(Pt 2):568–579.

Article  CAS  PubMed  Google Scholar 

Khan P, Fatima M, Khan MA, Batra SK, Nasser MW. Emerging role of chemokines in small cell lung cancer: road signs for metastasis, heterogeneity, and immune response. Semin Cancer Biol. 2022;87:117–126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goto M, Liu M. Chemokines and their receptors as biomarkers in esophageal cancer. Esophagus. 2020;17:113–121.

Article  PubMed  Google Scholar 

Saavedra-Garcia P, Fan LY, Lam EW. Multifaceted link between metabolism and cancer. Mol Cell Endocrinol. 2018;462(Pt B):65–66.

Article  CAS  PubMed  Google Scholar 

Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep. 2012;32:1–15.

Article  CAS  PubMed  Google Scholar 

Sgambato A, Cittadini A. Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci. 2010;14:263–268.

CAS  PubMed  Google Scholar 

Shrivastava MS, Hussain Z, Giricz O et al. Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle. 2014;13:3320–3327.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu J, Li JQ, Chen QL et al. Advances in research on the effects and mechanisms of chemokines and their receptors in cancer. Front Pharmacol. 2022;13:920779.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Yang Z, Lu W et al. Chemokines and chemokine receptors: a new strategy for breast cancer therapy. Cancer Med. 2020;9:3786–3799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujikawa M, Koma YI, Hosono M et al. Chemokine (C-C Motif) ligand 1 derived from tumor-associated macrophages contributes to esophageal squamous cell carcinoma progression via CCR8-mediated Akt/proline-rich Akt substrate of 40 kDa/mammalian target of rapamycin pathway. Am J Pathol. 2021;191:686–703.

Article  CAS  PubMed  Google Scholar 

Kodama T, Koma YI, Arai N et al. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways. Lab Investig. 2020;100:1140–1157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Zheng S, Liu T et al. MCP2 activates NF-kappaB signaling pathway promoting the migration and invasion of ESCC cells. Cell Biol Int. 2018;42:365–372.

Article  CAS  PubMed  Google Scholar 

Ding Y, Shimada Y, Maeda M et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:3406–3412.

CAS  PubMed  Google Scholar 

Wang H, Guo Q, Wang M, Liu C, Tian Z. PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma. Oncol Lett. 2023;26:500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen G, Teng Z, Zhu Z, Li X. miR-145-3p hampers the malignant progression of esophageal carcinoma via CXCL5 downregulation. Anal Cell Pathol (Amst). 2022;2022:5418356.

PubMed  PubMed Central  Google Scholar 

Hosono M, Koma YI, Takase N et al. CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells. Oncotarget. 2017;8:106071–106088.

Article  PubMed  PubMed Central  Google Scholar 

Yue D, Liu S, Zhang T et al. NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma. Cancer Biol Med. 2021;18:705–720.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li P, Chen X, Qin G et al. Maelstrom directs myeloid-derived suppressor cells to promote esophageal squamous cell carcinoma progression via activation of the Akt1/RelA/IL8 signaling pathway. Cancer Immunol Res. 2018;6:1246–1259.

Article  CAS  PubMed  Google Scholar 

Chen H, Sun G, Han Z, et al. Anti-CXCL8 autoantibody: a potential diagnostic biomarker for esophageal squamous cell carcinoma. Medicina (Kaunas). 2022;58:1480.

Article  PubMed  PubMed Central  Google Scholar 

Lukaszewicz-Zajac M, Paczek S, Muszynski P, Kozlowski M, Mroczko B. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients. Clin Exp Med. 2019;19:191–199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogura M, Takeuchi H, Kawakubo H et al. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma. Surgery. 2013;154:512–520.

Article  PubMed  Google Scholar 

Li J, Gu X, Wan G et al. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts. J Transl Med. 2023;21:248.

Article  CAS